This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Its Association With Microangiopathic Hemolytic Anemia and Thrombocytopenia

Steven J. Jubelirer, MD

Arch Intern Med. 1991;151(6):1221-1223.

Abstract
Four patients with primary pulmonary hypertension, microangiopathic hemolysis, and thrombocytopenia were seen at the Charleston (WVa) Area Medical Center between 1983 and 1988. Characteristic laboratory and clinical features of these patients were the following: mild anemia, reticulocytosis, low serum haptoglobin value, microangiopathic red blood cell changes on peripheral blood smear, mild to moderate thrombocytopenia, normal clotting studies (ie, prothrombin time, partial thromboplastin time, fibrinogen), negative direct Coombs' test, negative glucose water test, normal serum urea nitrogen and creatinine levels, lack of improvement of hemolysis and thrombocytopenia in response to vasodilators or calcium channel blockers, and severe plexiform lesions in the pulmonary vasculature with fibrin deposition at autopsy. The hemolysis and thrombocytopenia probably developed as a result of flow through the fibrin deposition in the plexiform lesions in the pulmonary circulation and subsequent shearing of red blood cells and platelets.

(Arch Intern Med. 1991;151:1221-1223)

Author Affiliations
From the Charleston Area Medical Center, Cancer Care Center of Southern West Virginia, and the Department of Hematology/Oncology, West Virginia University School of Medicine, Charleston Division, Charleston WVa.

Footnotes
Accepted for publication August 13, 1990.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hemodynamics and Epoprostenol Use Are Associated With Thrombocytopenia in Pulmonary Arterial Hypertension
Chin et al.
Chest 2009;135:130-136.
ABSTRACT | FULL TEXT  

Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
Morris et al.
JAMA 2005;294:81-90.
ABSTRACT | FULL TEXT  

The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease
Rother et al.
JAMA 2005;293:1653-1662.
ABSTRACT | FULL TEXT  

Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension
Egermayer et al.
Thorax 1999;54:161-168.
FULL TEXT